SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001735276-19-000089
Filing Date
2019-08-13
Accepted
2019-08-13 16:09:18
Documents
2
Period of Report
2019-08-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 2848
2 EDGAR SUPPORTING DOCUMENT poulton_20190813poa.txt EX-24 4084
  Complete submission text file 0001735276-19-000089.txt   8314
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Poulton Jeffrey V. (Reporting) CIK: 0001782962 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36407 | Film No.: 191020704